
    
      PRIMARY OBJECTIVE:

      I. To assess the proportion of patients with metastatic cancer who anticipate cure before
      starting immunotherapy.

      SECONDARY OBJECTIVES:

      I. To determine if expectations of cure are associated with quality of life and distress.

      II. To determine if patients' perceptions differ by gender, age, and ethnicity.

      OUTLINE:

      Patients complete surveys over 30 minutes about sociodemographic information and perception
      of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety,
      over 10 minutes about depression, and over 30 minutes about physical well-being. Patients'
      medical records are reviewed.
    
  